SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-06
👔
REGENXBIO Inc.
@RGNX_InsiderForm 4 Filing: PAKOLA STEVE Sells $46,461.5 of $RGNX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
REGENXBIO Inc.
Ticker: $RGNX
Transaction Value
$46,461.5
Price/Share: $10.75
transaction date
2026-07-02
Shares: 4,322
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, PAKOLA STEVE, holds the title of Chief Medical Officer at REGENXBIO Inc..
On 2026-07-02, the insider transacted 4,322 shares.The shares were transacted at a weighted average price of $10.75 per share, resulting in a total market-relevant value of $46,461.5.
Executive Summary Summary
PAKOLA STEVE (Chief Medical Officer) sold $46K of $RGNX
Post-Transaction Position: 213,009 shares
SEC Accession No: 0001700659-26-000014 (CIK: 1700659)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.